Bicocca Open Archive

Logo unimib boa
OGGIONI, NORBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.344
EU - Europa 4.774
AS - Asia 2.814
SA - Sud America 102
OC - Oceania 29
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 21
Totale 17.105
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.162
SG - Singapore 1.155
DE - Germania 915
CN - Cina 881
SE - Svezia 843
IE - Irlanda 673
IT - Italia 621
UA - Ucraina 531
RU - Federazione Russa 460
HK - Hong Kong 312
GB - Regno Unito 255
CA - Canada 173
VN - Vietnam 132
FI - Finlandia 122
AT - Austria 112
BR - Brasile 86
IN - India 73
FR - Francia 68
DK - Danimarca 67
ID - Indonesia 62
KR - Corea 59
JP - Giappone 37
NL - Olanda 34
TR - Turchia 28
BE - Belgio 21
MY - Malesia 21
IR - Iran 19
EU - Europa 18
NZ - Nuova Zelanda 17
PL - Polonia 13
AU - Australia 12
EG - Egitto 9
CZ - Repubblica Ceca 7
ES - Italia 7
AR - Argentina 5
MX - Messico 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
CL - Cile 4
HR - Croazia 4
HU - Ungheria 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
BD - Bangladesh 3
IQ - Iraq 3
KG - Kirghizistan 3
PK - Pakistan 3
RS - Serbia 3
A1 - Anonimo 2
AL - Albania 2
CH - Svizzera 2
CO - Colombia 2
GT - Guatemala 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
NG - Nigeria 2
PT - Portogallo 2
SC - Seychelles 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BY - Bielorussia 1
CG - Congo 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
GE - Georgia 1
IL - Israele 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 17.105
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.879
Woodbridge 819
Singapore 747
Chandler 706
Dublin 653
Jacksonville 543
Houston 525
Fairfield 455
Wilmington 446
Frankfurt am Main 433
Dearborn 424
Ashburn 355
Hong Kong 291
New York 270
Princeton 244
Milan 243
Santa Clara 228
Seattle 174
Nanjing 173
Boardman 170
Cambridge 137
Shanghai 116
Vienna 108
Lachine 89
Dong Ket 78
Altamura 73
Lawrence 71
Beijing 67
Jakarta 61
Guangzhou 59
Nanchang 59
Council Bluffs 49
Fremont 45
Andover 42
Shenyang 42
Grafing 40
Los Angeles 38
Jinan 36
Toronto 36
Jiaxing 34
Nürnberg 33
San Diego 31
Helsinki 29
Chicago 26
Falls Church 26
Ottawa 26
Tianjin 25
Zhengzhou 25
Daejeon 24
Kunming 23
Mountain View 23
Hangzhou 22
Hebei 22
Pune 22
Changsha 21
Brussels 20
Sacramento 19
Dallas 17
Leawood 16
Nuremberg 15
Ningbo 14
Philadelphia 14
Edmonton 13
Huizen 13
Rome 13
Bergamo 12
Carate Brianza 12
Norwalk 12
Pasir Mas 12
Regensburg 12
Shinjuku 12
Phoenix 11
Taizhou 11
Auburn Hills 10
Hefei 10
Kiev 9
London 9
San Mateo 9
Yongin-si 9
Cagliari 8
Codroipo 8
Canazei 7
Detroit 7
São Paulo 7
Washington 7
Wuhan 7
Changchun 6
Fuzhou 6
Lissone 6
Mainz 6
Perugia 6
Rio de Janeiro 6
Tehran 6
Ankara 5
Auckland 5
Clarks Summit 5
Frederick 5
Haikou 5
Laurel 5
Melzo 5
Totale 11.868
Salva come PNG Salva come JPEG
Nome #
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 320
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 309
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 308
Age-related changes in the function and structure of the peripheral sensory pathway in mice 305
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 293
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 249
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 246
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 236
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 225
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 223
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 220
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 214
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 209
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 208
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 203
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 203
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 203
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 201
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 194
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 192
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 189
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 189
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 188
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 185
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 184
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 180
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 180
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 179
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 179
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 175
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 172
Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor 169
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 167
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 167
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 167
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 167
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 167
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 164
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 162
Lipoplatin tm: a less neurotoxic formulation of cisplatin 162
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 161
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 161
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 159
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 159
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 158
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 157
Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration 156
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 153
Granulocytes in actively induced Lewis rat EAE 153
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 150
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 148
Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis 147
Erythropoietin both protects from and reverses experimental diabetic neuropathy 146
Organic cation transporter 2 mRNA expression in dorsal root ganglia neurons 146
Actively induced EAE in Lewis rats: Characterization of spleen and spinal cord infiltrating lymphocytes by flow cytometry during the course of the disease 145
Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis 144
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 144
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 144
Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis 143
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 143
Characterization of spleen and spinal cord infiltrating lymphocytes during actively induced EAE in Lewis rats. 142
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 142
Regression of diabetic complications by islet transplantation in the rat 138
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 138
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 138
Multimodal experimental approach to the study of human neurological diseases 136
Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy 135
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 135
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 134
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 133
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 132
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 131
The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats 129
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain 128
Effect of proteasome inhibition on the central and peripheral nervous system 128
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 127
Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis 124
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 124
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 124
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 123
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model. 120
Effect of different chronic treatment modalities on the peripheral neurotoxicity of sagopilone in rats: a multimodal analysis 119
Functional recovery with syngeneically transplanted microcapsulated pancreatic islets in streptozotocin-induced diabetic rats. 117
Characterization of Glutamate Transporters in Peripheral Nervous System. 117
Effects of palmitoylethanolamide (pea) in cisplatin-induced peripheral neuropathy in mice. 115
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 111
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS 110
Neurotoxicity and neuropatic pain induced by Bortezomib:evaluation of peripheral nerve fibres from a clinical to an ultrastructural level 108
Evaluation of the neuroprotective effect of acetyl-l-carnitine in myeloma-bearing mice treated with bortezomib 105
Neurotoxicity ad neuropathic pain induced by Bortezomib: evaluation of peripheral nerve fibres from a clinical to an ultrastructural level. 105
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 104
Biodistrubution and toxicology of two PFCs intravenously injected in rats 103
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 102
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 102
CHARACTERIZATION OF PERIPHERAL NEUROPATHY INDUCED BY CHRONIC CISPLATIN ADMINISTRATION IN SEVERAL MICE MODELS 101
STUDY OF THE CALCITONIN GENE-RELATED PEPTIDE-POSITIVE INTRAEPIDERMAL NERVE FIBERS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY 101
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 101
L-serine supplementation suppresses the formation of neurotoxic deoxysphingolipids and improves neuropathy in a type 1 diabetic rat model 95
Different strains of mice are differently susceptible to cisplatin-induced painful peripheral neuropathy (cipn): role of pharmacogenomics? 95
The new analgesic CR4056 effectively abrogates neuropathic pain induced by Bortezomib in rats 94
Totale 16.036
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.479
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.479
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020710 0 0 0 0 0 0 0 0 265 212 199 34
2020/20212.346 128 76 259 252 205 197 265 197 205 194 132 236
2021/20221.395 81 139 137 127 96 142 65 76 57 116 102 257
2022/20232.668 297 735 235 260 199 431 34 139 214 30 52 42
2023/20242.035 65 62 79 67 274 536 351 89 101 40 23 348
2024/20252.744 283 607 355 210 350 119 203 169 448 0 0 0
Totale 18.008